Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 20:47:50 - browse：2

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： FDA's Woodcock to retire early next year

WSS

An Ebola outbreak presents a new mystery involving children

Hospitals look to new technology to keep health care workers safe

CRISPR pioneers react to Casgevy, first gene

Choosing scientific sides in the fight against Alzheimer's

Former Georgia lieutenant governor says he received grand jury subpoena

Readout LOUD podcast: A CRISPR milestone, biotech mixology

hotspot

Wikipedia

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The painfully weak evidence on taking collagen to treat arthritis

At least 13 dead in Texas as scorching temps continue

Choosing scientific sides in the fight against Alzheimer's

At least 13 dead in Texas as scorching temps continue

An Ebola outbreak presents a new mystery involving children

Bright Health sells Medicare Advantage business to Molina

More regulation could be coming for drug ads

State Dept. review finds Biden bears some blame for Afghanistan failures

Travel bans should be based on evidence, not politics or fear

leisure time

Hospitals look to new technology to keep health care workers safe

Germany receives 178 compensation applications from gay servicepeople over discrimination

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Zapping the brain for stroke rehab: Pivotal clinical trial begins

U.K. considers world's first use of meningitis vaccine to address gonorrhea

knowledge

hotspot

hotspot

knowledge